142 related articles for article (PubMed ID: 7521091)
1. The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American UroLume Study Group.
Oesterling JE; Kaplan SA; Epstein HB; Defalco AJ; Reddy PK; Chancellor MB
Urology; 1994 Sep; 44(3):353-62. PubMed ID: 7521091
[TBL] [Abstract][Full Text] [Related]
2. A modified prostatic UroLume Wallstent for healthy patients with symptomatic benign prostatic hyperplasia: a European Multicenter Study.
Guazzoni G; Montorsi F; Coulange C; Milroy E; Pansadoro V; Rubben H; Sarramon JP; Williams G
Urology; 1994 Sep; 44(3):364-70. PubMed ID: 7521092
[TBL] [Abstract][Full Text] [Related]
3. Long-term experience utilizing a new balloon expandable prostatic endoprosthesis: the Titan stent. North American Titan Stent Study Group.
Kaplan SA; Chiou RK; Morton WJ; Katz PG
Urology; 1995 Feb; 45(2):234-40. PubMed ID: 7855972
[TBL] [Abstract][Full Text] [Related]
4. The UroLume endoprosthesis: a summary of the European and North American experience.
Oesterling JE
Prog Clin Biol Res; 1994; 386():561-75. PubMed ID: 7528427
[TBL] [Abstract][Full Text] [Related]
5. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia.
Masood S; Djaladat H; Kouriefs C; Keen M; Palmer JH
BJU Int; 2004 Dec; 94(9):1271-4. PubMed ID: 15610103
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia.
Cowles RS; Kabalin JN; Childs S; Lepor H; Dixon C; Stein B; Zabbo A
Urology; 1995 Aug; 46(2):155-60. PubMed ID: 7542818
[TBL] [Abstract][Full Text] [Related]
7. Transurethral electrovaporization of the prostate: a novel method for treating men with benign prostatic hyperplasia.
Kaplan SA; Te AE
Urology; 1995 Apr; 45(4):566-72. PubMed ID: 7536365
[TBL] [Abstract][Full Text] [Related]
8. Long-term followup of the North American multicenter UroLume trial for the treatment of external detrusor-sphincter dyssynergia.
Chancellor MB; Gajewski J; Ackman CF; Appell RA; Bennett J; Binard J; Boone TB; Chetner MP; Crewalk JA; Defalco A; Foote J; Green B; Juma S; Jung SY; Linsenmeyer TA; MacMillan R; Mayo M; Ozawa H; Roehrborn CG; Shenot PJ; Stone A; Vazquez A; Killorin W; Rivas DA
J Urol; 1999 May; 161(5):1545-50. PubMed ID: 10210393
[TBL] [Abstract][Full Text] [Related]
9. Transurethral microwave treatment for benign prostatic hypertrophy: a randomised controlled clinical trial.
Bdesha AS; Bunce CJ; Kelleher JP; Snell ME; Vukusic J; Witherow RO
BMJ; 1993 May; 306(6888):1293-6. PubMed ID: 7686065
[TBL] [Abstract][Full Text] [Related]
10. Prostatic spiral versus prostatic urolume wallstent for urinary retention due to benign prostatic hyperplasia. A long-term comparative study.
Guazzoni G; Montorsi F; Bergamaschi F; Consonni P; Bellinzoni P; Rigatti P
Eur Urol; 1993; 24(3):332-6. PubMed ID: 7505225
[TBL] [Abstract][Full Text] [Related]
11. The UroLume stent in the management of benign prostatic hyperplasia.
Milroy E; Chapple CR
J Urol; 1993 Nov; 150(5 Pt 2):1630-5. PubMed ID: 7692100
[TBL] [Abstract][Full Text] [Related]
12. Minimally invasive prostatic urethral lift: surgical technique and multinational experience.
McNicholas TA; Woo HH; Chin PT; Bolton D; Fernández Arjona M; Sievert KD; Schoenthaler M; Wetterauer U; Vrijhof EJ; Gange S; Montorsi F
Eur Urol; 2013 Aug; 64(2):292-9. PubMed ID: 23357348
[TBL] [Abstract][Full Text] [Related]
13. Epithelializing stent for benign prostatic hyperplasia: a systematic review of the literature.
Armitage JN; Cathcart PJ; Rashidian A; De Nigris E; Emberton M; van der Meulen JH
J Urol; 2007 May; 177(5):1619-24. PubMed ID: 17437773
[TBL] [Abstract][Full Text] [Related]
14. [Use of UroLume as an alternative to the treatment of recurrent stenosis of bulbar urethra and obstructive prostatic hyperplasia in patients with high surgical risk].
Serrano-Brambila EA; Camacho-Carvajal JC; Moreno-Aranda J; Martínez-Sánchez R
Gac Med Mex; 2003; 139(5):435-48. PubMed ID: 14635562
[TBL] [Abstract][Full Text] [Related]
15. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention.
Ghalayini IF; Al-Ghazo MA; Pickard RS
BJU Int; 2005 Jul; 96(1):93-7. PubMed ID: 15963128
[TBL] [Abstract][Full Text] [Related]
16. Microwave thermotherapy for benign prostatic hyperplasia.
Hoffman RM; Monga M; Elliot SP; Macdonald R; Wilt TJ
Cochrane Database Syst Rev; 2007 Oct; (4):CD004135. PubMed ID: 17943811
[TBL] [Abstract][Full Text] [Related]
17. Outcome of vaportrode transurethral vaporization of the prostate using pressure-flow urodynamic criteria.
Desautel MG; Burney TL; Diaz PA; Austria A; Badlani GH
Urology; 1998 Jun; 51(6):1013-7. PubMed ID: 9609642
[TBL] [Abstract][Full Text] [Related]
18. Impact of prostate size on the outcome of transurethral laser evaporation of the prostate for benign prostatic hyperplasia.
Narayan P; Tewari A; Fournier G; Toke A
Urology; 1995 May; 45(5):776-82. PubMed ID: 7538239
[TBL] [Abstract][Full Text] [Related]
19. The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group.
Roehrborn CG; Oesterling JE; Auerbach S; Kaplan SA; Lloyd LK; Milam DE; Padley RJ
Urology; 1996 Feb; 47(2):159-68. PubMed ID: 8607227
[TBL] [Abstract][Full Text] [Related]
20. Long-term clinical results and quality of life after insertion of a self-expanding flexible endourethral prosthesis.
Anjum MI; Chari R; Shetty A; Keen M; Palmer JH
Br J Urol; 1997 Dec; 80(6):885-8. PubMed ID: 9439402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
